期刊文献+

妊娠相关蛋白A初始中位数建立及早期筛查价值探讨 被引量:3

Study on the Establishment of the Initial Median of Pregnancy Associated Plasma Protein A and Its Value in the Early Screening
下载PDF
导出
摘要 【目的】建立岳阳地区早孕期孕妇的血清妊娠相关蛋白A(PAPP—A)初始中位数,并探讨其在早孕期的产前筛查价值。【方法】采用时间分辨免疫荧光分析技术,对本院孕9~136周的2786例本地孕妇进行母血清产前筛查标志物PAPP—A检测,并利用非线性加权回归拟合方程计算早孕期初始中位数,同时随访其妊娠结局。【结果】建立了岳阳地区早孕期PAPP—A的初始中位数,其孕周变化趋势与软件内嵌参数一致,平均高约24%;初始中位数与软件内嵌参数相比,检测了更多的出生缺陷,并检测了所有染色体病患儿。【结论】种族、实验室系统误差对孕妇筛查标志物PAPPA的预期中位数浓度有影响,各筛查实验室应建立自己的初始中位数,以保证结果的可靠性。 [Objective] To establish the initial median of pregnancy associated plasma protein A(PAPP-A) in pregnant women during the first trimester gestation in Yueyang area, and to explore its value in the prenatal screening during early pregnancy. [Methods]The dissociation enhanced lanthanide fluoroimmunoassay was used to detect the maternal serum marker PAPP-A for prenatal screening in 2786 pregnant women at 9- 136 weeks. The initial median of PAPP-A during early pregnancy was calculated by using nonlinear weight regression fitting equation. Meanwhile the pregnant outcome was followed up. [Results]The initial median of PAPPA during early pregnancy in Yueyang area was established, and its change tendency with gestational age was in accordance with the original parameter inserted in software with above 24% at average. Compared with the o- riginal parameter inserted in software, the initial median could detect more birth defects and all chromosome disease children. [Conclusion]The differences among races and laboratory systems can influence the expected median concentration of the prenatal screening marker in maternal serum. Therefore, each laboratory should establish its own initial median in order to ensure the reliability of the results.
出处 《医学临床研究》 CAS 2011年第8期1480-1482,共3页 Journal of Clinical Research
关键词 妊娠蛋白质类 pregnancy proteins
  • 相关文献

参考文献6

二级参考文献17

  • 1朱宝生,焦存仙,朱姝,董旭东,胡云英,刘云霞,冯怀英,刘娟,唐新华,张云霞,王瑞红,祝杏珍,章晓梅.唐氏综合征发生率及其受产前筛查干预的研究[J].中华妇幼临床医学杂志(电子版),2005,1(1):20-22. 被引量:31
  • 2董旭东,焦存仙,朱宝生,罗世香,吴云萍,刘宁.血清PAPP-A在正常孕妇及子痫前期患者中的研究[J].中国优生与遗传杂志,2005,13(10):63-64. 被引量:3
  • 3Beaman J M, Goldie DJ. Second trimester screening for Down's syndrome :7 years experience [ J ]. J Med Sereen, 2001,8 ( 3 ) : 128 - 131.
  • 4Cuckle H S, Wald NJ, Thompson SG. Estimating a woman's risk of having a pregnancy associated with I) own's syndrome using her age and serum alpha -fetoprotein level[ J ]. Br J Obstet Gynecol, 1987,94 (5) :387 -402.
  • 5Claik L,et al. Precise gaussian distribution functions of maternal serum α - fetoprotcin and flee - β - subunit of human chronic gonadotropin for trisomy 21 screening:improved aceuracy for patient counseling [ J ]. Am J Obstet Gynecol, 1997,177 (4) : 882 - 886.
  • 6O Brien W F, Knuppel RA, Torres C, et al. Potential prenatal predictions of Down's syndrome:a statislical analysis[ J ]. Am J Obstet Gynecol,1990,163 (6 Pt 1 ) :1796 - 1798.
  • 7Muller F, Dreux S,Oury JF,et al. Down's syndrome maternal serum marker screening after 18 weeks' gestation [ J ]. Prenatal Diagn, 2002 Nov ,22( 11 ) :1001 - 1004.
  • 8胡娅莉,张建伟,余小金,等.MoM标化方法及其在产前筛检中的应用.第四届全国产前诊断学术研讨会论文集[C].
  • 9Macri JN, Kasturi RV, Krantz DA, et al. Matethal serum alpha -fetoprotein(MsAFP) patient -specific risk reporting: its use an misuse [ J]. Am J Hum Genet, 1990,46:587 -590.
  • 10Hsu J J, Hsieh TT, Hsieh FJ. Down' s syndrome screening in an Asian population using alpha-fetoprotein and free β-HCG: a report of the Taiwan Down' s syndrome screening group. Obstet Gynecol,1996,87 (6): 943-947

共引文献54

同被引文献32

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部